Technical Analysis for ITOS - iTeos Therapeutics, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 10.26 | -5.09% | -0.55 |
ITOS closed down 5.09 percent on Monday, March 18, 2024, on 62 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 50 DMA | Bearish | 0.00% | |
Stochastic Reached Oversold | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Crossed Above 50 DMA | Bullish | -5.09% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | -5.09% | |
NR7 | Range Contraction | -5.09% | |
Inside Day | Range Contraction | -5.09% | |
Fell Below 20 DMA | Bearish | -4.38% | |
Fell Below 50 DMA | Bearish | -4.38% | |
MACD Bearish Signal Line Cross | Bearish | -4.38% |
Alert | Time |
---|---|
Down 5% | about 14 hours ago |
60 Minute Opening Range Breakdown | about 15 hours ago |
Down 3% | about 20 hours ago |
Fell Below 50 DMA | about 20 hours ago |
Fell Below Previous Day's Low | about 20 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/13/2024
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for cancer patients. Its product pipeline includes EOS-850, a small molecule antagonist of the adenosine A2a receptor; and EOS-448, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains. The company was founded in 2011 and is based in Cambridge, Massachusetts with an additional location in Gosselies, Belgium.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Adenosine Therapeutics For Cancer
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Adenosine Therapeutics For Cancer
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 18.24 |
52 Week Low | 8.2 |
Average Volume | 253,421 |
200-Day Moving Average | 11.50 |
50-Day Moving Average | 10.71 |
20-Day Moving Average | 11.03 |
10-Day Moving Average | 11.35 |
Average True Range | 0.57 |
RSI (14) | 42.86 |
ADX | 17.43 |
+DI | 18.60 |
-DI | 25.30 |
Chandelier Exit (Long, 3 ATRs) | 10.79 |
Chandelier Exit (Short, 3 ATRs) | 11.41 |
Upper Bollinger Bands | 12.23 |
Lower Bollinger Band | 9.82 |
Percent B (%b) | 0.18 |
BandWidth | 21.89 |
MACD Line | 0.12 |
MACD Signal Line | 0.23 |
MACD Histogram | -0.1101 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 11.07 | ||||
Resistance 3 (R3) | 11.16 | 10.98 | 10.94 | ||
Resistance 2 (R2) | 10.98 | 10.77 | 10.94 | 10.89 | |
Resistance 1 (R1) | 10.62 | 10.65 | 10.53 | 10.53 | 10.84 |
Pivot Point | 10.44 | 10.44 | 10.40 | 10.40 | 10.44 |
Support 1 (S1) | 10.08 | 10.23 | 9.99 | 9.99 | 9.68 |
Support 2 (S2) | 9.90 | 10.11 | 9.86 | 9.63 | |
Support 3 (S3) | 9.54 | 9.90 | 9.59 | ||
Support 4 (S4) | 9.45 |